Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
暂无分享,去创建一个
Charles J. Vaske | E. Collisson | Wei Wu | R. Cho | S. Benz | J. Z. Sanborn | D. Solomon | J. North | Andrew Nguyen | J. Golovato | M. Bloomer | Benjamin Goode | Meredith Stevers | K. McMullen | B. P. Perez White
[1] A. Rao,et al. Sebaceous Carcinoma , 2020, Definitions.
[2] Andrew D. Johnson,et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation , 2016, Nature Genetics.
[3] D. Lin,et al. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma , 2016, Oncogene.
[4] Prahlad T. Ram,et al. Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma , 2016, The Journal of pathology.
[5] Erika J. Thompson,et al. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates , 2016, Nature Communications.
[6] Nicolai J. Birkbak,et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.
[7] R. Cho,et al. Multiple Hereditary Infundibulocystic Basal Cell Carcinoma Syndrome Associated With a Germline SUFU Mutation. , 2016, JAMA dermatology.
[8] Arcadi Navarro,et al. The European Genome-phenome Archive of human data consented for biomedical research , 2015, Nature Genetics.
[9] Steven J. M. Jones,et al. Genomic Classification of Cutaneous Melanoma , 2015, Cell.
[10] Martin L. Miller,et al. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.
[11] J. Saurin,et al. Somatic MMR Gene Mutations as a Cause for MSI‐H Sebaceous Neoplasms in Muir–Torre Syndrome‐Like Patients , 2015, Human mutation.
[12] E. Hurst,et al. Sebaceous Carcinoma: Review of the Literature , 2015, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[13] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[14] James Robinson,et al. The IPD and IMGT/HLA database: allele variant databases , 2014, Nucleic Acids Res..
[15] Colin C Pritchard,et al. Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.
[16] Li Shang,et al. Genomic and molecular characterization of esophageal squamous cell carcinoma , 2014, Nature Genetics.
[17] Ira M. Hall,et al. SAMBLASTER: fast duplicate marking and structural variant read extraction , 2014, Bioinform..
[18] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[19] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[20] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[21] Joshua F. McMichael,et al. Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition , 2012, Nature.
[22] A. Lazar,et al. p53 Staining Correlates With Tumor Type and Location in Sebaceous Neoplasms , 2012, The American Journal of dermatopathology.
[23] Z. Siprashvili,et al. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. , 2012, Developmental cell.
[24] Ken Chen,et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..
[25] David Haussler,et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma , 2011, Proceedings of the National Academy of Sciences.
[26] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[27] Jian Li,et al. Temporal dissection of tumorigenesis in primary cancers. , 2011, Cancer discovery.
[28] J. V. Frei,et al. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II). Diploid malignancies with prolonged survival. , 1992, Cancer.
[29] A. Lazar,et al. Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications , 2010, Histopathology.
[30] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[31]
R. Durbin,et al.
Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P ,
2022
.
[32]
G. Dotto,et al.
Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression.
,
2004,
Seminars in cancer biology.
[33]
P. Propping,et al.
Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene?
,
1996,
Human Genetics.
[34]
I. McLean,et al.
Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data.
,
1982,
Human pathology.
[35]
S. Warren,et al.
Tumors of Sebaceous Glands.
,
1943,
The American journal of pathology.